This trial tests a drug's safety and effectiveness in teens with moderate-to-severe eczema.
- Atopic Dermatitis
1 Primary · 4 Secondary · Reporting Duration: Up to 52 Weeks
Awards & Highlights
1 Treatment Group
1 of 1
170 Total Participants · 1 Treatment Group
Primary Treatment: Rocatinlimab · No Placebo Group · Phase 3
Who is running the clinical trial?
Age 12 - 17 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does this research welcome participants younger than 75 years old?
"The conditions for enrolment in the present trial necessitate that participants must be between 12 and 17 years old. Moreover, there are 104 clinical trials offered to minors and 170 studies open to elderly individuals over 65." - Anonymous Online Contributor
What adverse effects have been reported as a result of taking Rocatinlimab?
"Our team has concluded that rocatinibimab is a safe intervention, awarding it the highest possible rating of 3. This determination was made based on prior evidence demonstrating its efficacy and numerous studies confirming its safety profile." - Anonymous Online Contributor
How many venues are facilitating this research endeavor?
"Currently, prospective participants can register for this trial at 5 distinct sites across the US. These locations are in Portland, Corpus Christi and Dallas to name a few. To minimize travel costs associated with participating, it is best to select the clinic closest you." - Anonymous Online Contributor
What is the size of the cohort enrolled in this clinical research?
"This research trial necessitates the enrolment of 170 suitable individuals. Potential participants can take part at either Oregon Medical Research Center in Portland or Driscoll Childrens Hospital located in Corpus Christi, Texas." - Anonymous Online Contributor
Is there still room to enroll participants in this trial?
"Affirmative, according to the information hosted on clinicaltrials.gov this experiment is recruiting participants as of now. The trial was initially posted on January 30th 2023 and modified most recently on February 3rd 2023. It seeks 170 volunteers from 5 different medical centers." - Anonymous Online Contributor
Is there a predetermined criteria for participation in this research?
"This clinical trial is selecting 170 juvenile patients with atopic dermatitis to participate. The selection criteria necessitates that candidates are between the ages of 12 and 17, have had diagnosis for a minimum 6 months, demonstrate inadequate response to topical corticosteroid therapy in combination or not with TCI's, an EASI score exceeding 16 points and vIGA-AD score above 3 as well as more than 10% BSA affected by AD at enrollment." - Anonymous Online Contributor